Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D9WQD2
|
|||
| Drug Name |
V114
|
|||
| Synonyms |
MK-V114; 15-valent im pneumococcal conjugate vaccine (pneumococcal disease), Merck & Co
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Pneumococcal infection [ICD-11: CA00-CA40] | Phase 3 | [1] | |
| Myelodysplastic syndrome [ICD-11: 2A37; ICD-9: 238.7] | Phase 2 | [2] | ||
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04384107) Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Healthy Japanese Infants (V114-033). U.S. National Institutes of Health. | |||
| REF 2 | ClinicalTrials.gov (NCT01215188) A Study of Pneumococcal Conjugate Vaccine (V114) Compared to a Marketed Vaccine (V114-003 AM2). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.